CLINICAL_TRIALS ClinicalTrials.gov record update

Phase I and Randomized Phase II Double Blind Clinical Trial of Cisplatin and Etoposide in Combination With Veliparib (ABT-888) or Placebo as Frontline Therapy for Extensive Stage Small Cell Lung Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01642251
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:11.502722+00:00
Published At: 2019-02-05T00:00:00+00:00
Record Updated At: 2023-05-06
Results Posted At: 2019-02-05
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Extensive Stage Small Cell Lung Carcinoma", "Large Cell Lung Carcinoma", "Neuroendocrine Carcinoma", "Small Cell Carcinoma", "Stage IV Non-Small Cell Lung Cancer AJCC v7"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-05-06"
protocolSection.identificationModule.nctId: "NCT01642251"
protocolSection.identificationModule.officialTitle: "Phase I and Randomized Phase II Double Blind Clinical Trial of Cisplatin and Etoposide in Combination With Veliparib (ABT-888) or Placebo as Frontline Therapy for Extensive Stage Small Cell Lung Cancer"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2019-02-05"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.